Predictors of fracture while on treatment with oral bisphosphonates: A population-based cohort study
Journal of Bone and Mineral Research, 06/13/2013PrietoAlhambra D et al. –
Although oral bisphosphonates (BP) are highly effective in preventing fractures, some patients will fracture while on treatment. Even among high compliers, 3.4% of oral BP users will fracture every year. Older age, underweight, vitamin D deficiency, proton pump inhibitors (PPI) use, previous fracture and inflammatory arthritides increase risk. Monitoring strategies and/or alternative therapies should be considered for these patients.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.